NCT06834503View on ClinicalTrials.gov

Bioequivalence Study of Clonazepam 2 Mg Tablets

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

November 1, 2025

Conditions

HealthyHealthy Donors

Interventions

DRUG

Rivotril®

Rivotril® 2 mg

DRUG

Clonazepam TQ 2 mg

Test

All Listed Sponsors

lead

Centro de Atencion e Investigacion Medica

NETWORK